Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/04/202312:50PMPR Newswire (US)Jesse Sasomsup is accepted into Forbes Business Council
06/04/202312:46PMPR Newswire (US)OptimEyes.AI Showcases ROAR™ (Risk Orchestration Automation & Response) at the Gartner® Security & Risk Management Summit 2023
06/04/202312:25PMPR Newswire (Canada)Forest fires - AMENDMENT TO THE TERRITORY ON WHICH ACCESS TO THE FOREST IN LANDS IN THE DOMAIN OF THE STATE IS PROHIBITED AND ON WHICH ROADS ARE CLOSED
06/04/202312:00PMPR Newswire (US)Cupshe Celebrates 8th Birthday with Exclusive Collection in Collaboration with Chanel Iman, Heather Rae El Moussa, and Brittany Cartwright
06/04/202312:00PMPR Newswire (Canada)Rassemblement à Montréal pour appuyer les salarié(e)s de Vidéotron - Gatineau
06/04/202312:00PMPR Newswire (US)SOUTH JERSEY BEHAVIORAL HEALTH RESOURCES PROVIDES NOTICE OF DATA PRIVACY EVENT
06/04/202311:00AMPR Newswire (US)The 31st PT EXPO China Opens in Beijing
06/04/202310:20AMPR Newswire (US)Javier Cardenal sells Multi-family Development Site in Cutler Bay, Florida for Family Office
06/04/202310:02AMPR Newswire (US)Billboard, Music Week, and DJ Times Charting Recording Artist, NOAH, Releases Groundbreaking Single "BABYMAKER"
06/04/202310:00AMPR Newswire (Canada)Autonomie alimentaire et productivité des entreprises - Québec annonce une aide de 115 273 $ au moulin de la Seigneurie des Aulnaies pour la transformation automatisée de farines biologiques
06/04/202310:00AMPR Newswire (Canada)Le gouvernement du Québec accorde plus de 300 000 $ à Ex Machina pour le rayonnement de la culture
06/04/20239:14AMPR Newswire (US)New Long-Term Data from the CHRYSALIS Study Show Median Progression-Free Survival Not Reached after 33.6 Months of Follow-Up with First-Line Use of RYBREVANT® (amivantamab-vmjw) and Lazertinib Combination Therapy in Patients with Treatment-Naïve EGFR-Mut
06/04/20239:00AMBusiness WireResearch Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer
06/04/20239:00AMBusiness WirePuma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting NASDAQ:PBYIPuma Biotechnology Inc
06/04/20239:00AMPR Newswire (US)Haute Residence and Katharine A Rutland Continue Their Real Estate Partnership Into Second Year
06/04/20239:00AMPR Newswire (Canada)Déclaration du premier ministre à l'occasion de la Journée des Forces armées canadiennes
06/04/20239:00AMPR Newswire (Canada)Statement by the Prime Minister on Canadian Armed Forces Day
06/04/20238:30AMPR Newswire (US)Learn How to Open a Coffee Shop in Michigan in 2023 from Startup Experts at Crimson Cup Coffee & Tea
06/04/20238:10AMPR Newswire (US)Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma
06/04/20238:00AMBusiness WirePromising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023 NASDAQ:SMMTSummit Therapeutics Inc
06/04/20238:00AMBusiness WireTAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial NASDAQ:AZNAstraZeneca PLC
06/04/20238:00AMBusiness WireNucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice
06/04/20238:00AMBusiness WireFour-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer NYSE:BMYBristol Myers Squibb Co
06/04/20238:00AMBusiness WireELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer NASDAQ:IMGNImmunoGen Inc
06/04/20238:00AMPR Newswire (US)Visible Shop has won the Best Design Medal at London Design Biennale 2023
06/04/20238:00AMPR Newswire (US)Phase 3 SWOG Cancer Research Network trial, led by a City of Hope researcher, demonstrates one-year progression-free survival in 94% of patients with Stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
06/04/20238:00AMPR Newswire (Canada)/R E P R I S E -- Modernisation du stade Gary-Carter : un coup de circuit!/
06/04/20238:00AMPR Newswire (Canada)Festivals et événements de la saison printanière 2023 - Le gouvernement du Québec accorde 50 000 $ au Concours Prix d'Europe
06/04/20238:00AMPR Newswire (US)Operations Strategist, Paul Wann, Named Chief Operating Officer at HPI
06/04/20238:00AMPR Newswire (US)AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023 NASDAQ:AMGNAmgen Inc
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: us D: 20230604 18:37:43